Abstract

Understanding the principles of colonization resistance of the gut microbiome to the pathogen Clostridioides difficile will enable the design of defined bacterial therapeutics. We investigate the ecological principles of community resistance to C. difficile using a synthetic human gut microbiome. Using a dynamic computational model, we demonstrate that C. difficile receives the largest number and magnitude of incoming negative interactions. Our results show that C. difficile is in a unique class of species that display a strong negative dependence between growth and species richness. We identify molecular mechanisms of inhibition including acidification of the environment and competition over resources. We demonstrate that Clostridium hiranonis strongly inhibits C. difficile partially via resource competition. Increasing the initial density of C. difficile can increase its abundance in the assembled community, but community context determines the maximum achievable C. difficile abundance. Our work suggests that the C. difficile inhibitory potential of defined bacterial therapeutics can be optimized by designing communities featuring a combination of mechanisms including species richness, environment acidification, and resource competition.

Details

Title
Negative interactions determine Clostridioides difficile growth in synthetic human gut communities
Author
Hromada, Susan 1 ; Qian, Yili 2   VIAFID ORCID Logo  ; Jacobson, Tyler B 3   VIAFID ORCID Logo  ; Clark, Ryan L 2 ; Watson, Lauren 4 ; Safdar, Nasia 4 ; Daniel Amador‐Noguez 3 ; Venturelli, Ophelia S 5   VIAFID ORCID Logo 

 Department of Biochemistry, University of Wisconsin‐Madison, Madison, WI, USA; Microbiology Doctoral Training Program, University of Wisconsin‐Madison, Madison, WI, USA 
 Department of Biochemistry, University of Wisconsin‐Madison, Madison, WI, USA 
 Department of Bacteriology, University of Wisconsin‐Madison, Madison, WI, USA 
 Division of Infectious Disease, Department of Medicine, School of Medicine and Public Health, University of Wisconsin‐Madison, Madison, WI, USA; Department of Medicine, William S. Middleton Veterans Hospital Madison, Madison, WI, USA 
 Department of Biochemistry, University of Wisconsin‐Madison, Madison, WI, USA; Department of Bacteriology, University of Wisconsin‐Madison, Madison, WI, USA; Department of Chemical and Biological Engineering, University of Wisconsin‐Madison, Madison, WI, USA 
Section
Articles
Publication year
2021
Publication date
Oct 2021
Publisher
EMBO Press
e-ISSN
17444292
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2586272164
Copyright
© 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.